Negotiated Rates for Surgical Cancer Care in the Era of Price Transparency-Prices Reflect Market Competition.

ABSTRACT:

Objective

To measure commercial price variation for cancer surgery within and across hospitals.

Background

Surgical care for solid-organ tumors is costly, and negotiated commercial rates have been hidden from public view. The Hospital Price Transparency Rule, enacted in 2021, requires all hospitals to list their negotiated rates on their website, thus opening the door for an examination of pricing for cancer surgery.

Methods

This was a cross-sectional study using 2021 negotiated price data disclosed by US hospitals for the 10 most common cancers treated with surgery. Price variation was measured using within-hospital and across-hospital ratios. Commercial rates relative to cancer center designation and the Herfindahl-Hirschman Index at the facility level were evaluate

SUBMITTER: Rochlin DH 

PROVIDER: S-EPMC10840891 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature